Kezar Life Sciences (KZR) Total Liabilities (2021 - 2025)
Kezar Life Sciences (KZR) has disclosed Total Liabilities for 5 consecutive years, with $6.6 million as the latest value for Q4 2025.
- Quarterly Total Liabilities fell 76.32% to $6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Dec 2025, down 76.32% year-over-year, with the annual reading at $6.6 million for FY2025, 76.32% down from the prior year.
- Total Liabilities hit $6.6 million in Q4 2025 for Kezar Life Sciences, down from $14.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $33.7 million in Q4 2023 to a low of $6.6 million in Q4 2025.
- Historically, Total Liabilities has averaged $22.6 million across 5 years, with a median of $21.9 million in 2022.
- Biggest five-year swings in Total Liabilities: soared 105.78% in 2022 and later crashed 76.32% in 2025.
- Year by year, Total Liabilities stood at $21.1 million in 2021, then skyrocketed by 41.03% to $29.7 million in 2022, then grew by 13.37% to $33.7 million in 2023, then fell by 17.52% to $27.8 million in 2024, then plummeted by 76.32% to $6.6 million in 2025.
- Business Quant data shows Total Liabilities for KZR at $6.6 million in Q4 2025, $14.8 million in Q3 2025, and $17.3 million in Q2 2025.